Clinical significance of HAX-1 expression in laryngeal carcinoma

Auris Nasus Larynx

Volumn 42, Issue 4, 2015, Pages 299-304

  You, Yiwen ^a   Yao, Hao ^a   You, Bo ^a   Li, Xingyu ^a   Ni, Haosheng ^a   Shi, Si ^a   Shan, Ying ^a   Cao, Xiaolei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

HAX 1; Immunohistochemistry; Laryngeal carcinoma; Prognosis; Two step quantitative real time PCR; Western blot

Indexed keywords

HS1 ASSOCIATED PROTEIN X 1; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG; HAX1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME; WESTERN BLOTTING; AGED; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; GENETICS; HEAD AND NECK NEOPLASMS; KAPLAN MEIER METHOD; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPH NODE; METABOLISM; MIDDLE AGED; NECK DISSECTION; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPH NODES; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 84928924167     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2014.12.003     Document Type: Article

References (28)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Lefebvre J.L. Larynx preservation. Curr Opin Oncol 2012, 24:218-222.
3. Suzuki Y., Demoliere C., Kitamura D., Takeshita H., Deuschle U., Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol 1997, 158:2736-2744.
4. Fadeel B., Grzybowska E. HAX-1: a multifunctional protein with emerging roles in human disease. Biochim Biophys Acta 2009, 1790:1139-1148.
5. Sharp T.V., Wang H.W., Koumi A., Hollyman D., Endo Y., Ye H., et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 2002, 76:802-816.
6. Li W.B., Feng J., Geng S.M., Zhang P.Y., Yan X.N., Hu G., et al. Induction of apoptosis by Hax-1 siRNA in melanoma cells. Cell Biol Int 2009, 33:548-554.
7. Vafiadaki E., Arvanitis D.A., Pagakis S.N., Papalouka V., Sanoudou D., Kontrogianni-Konstantopoulos A., et al. The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell 2009, 20:306-318.
8. Gallagher A.R., Cedzich A., Gretz N., Somlo S., Witzgall R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci U S A 2000, 97:4017-4022.
9. Radhika V., Onesime D., Ha J.H., Dhanasekaran N. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem 2004, 279:49406-49413.
10. Matsuda G., Nakajima K., Kawaguchi Y., Yamanashi Y., Hirai K. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol Immunol 2003, 47:91-99.
11. Kawaguchi Y., Nakajima K., Igarashi M., Morita T., Tanaka M., Suzuki M., et al. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol 2000, 74:10104-10111.
12. Li M., Tang Y., Zang W., Xuan X., Wang N., Ma Y., et al. Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma. Diagn Pathol 2013, 8:47.
13. Wei X.J., Li S.Y., Yu B., Chen G., Du J.F., Cai H.Y. Expression of HAX-1 in human colorectal cancer and its clinical significance. Tumour Biol 2014, 35:1411-1415.
14. Mirmohammadsadegh A., Tartler U., Michel G., Baer A., Walz M., Wolf R., et al. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol 2003, 120:1045-1051.
15. Ramsay A.G., Keppler M.D., Jazayeri M., Thomas G.J., Parsons M., Violette S., et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res 2007, 67:5275-5284.
16. Trebinska A., Rembiszewska A., Ciosek K., Ptaszynski K., Rowinski S., Kupryjanczyk J., et al. HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer 2010, 10:76.
17. Kwiecinska A., Ottosson-Wadlund A., Ceder R., Grafstrom R.C., Bjorck E., Nordenskjold M., et al. HAX-1 expression in human B lymphoma. Leukemia 2011, 25:868-872.
18. Banerjee A., Saito K., Meyer K., Banerjee S., Ait-Goughoulte M., Ray R.B., et al. Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. J Virol 2009, 83:9663-9671.
19. Yu C., Chen K., Zheng H., Guo X., Jia W., Li M., et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30:894-901.
20. Simmen T. Hax-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease. Expert Opin Ther Targets 2011, 15:741-751.
21. Carlsson G., van't Hooft I., Melin M., Entesarian M., Laurencikas E., Nennesmo I., et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008, 264:388-400.
22. Dufva M., Olsson M., Rymo L. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol 2001, 82(Pt 7):1581-1587.
23. Kasashima K., Ohta E., Kagawa Y., Endo H. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J Biol Chem 2006, 281:36401-36410.
24. Han Y., Chen Y.S., Liu Z., Bodyak N., Rigor D., Bisping E., et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 2006, 99:415-423.
25. Lee A.Y., Lee Y., Park Y.K., Bae K.H., Cho S., Lee do H., et al. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells 2008, 25:86-90.
26. Sun S.J., Feng L., Zhao G.Q., Dong Z.M. HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells. Dig Dis Sci 2012, 57:1838-1846.
27. Almadori G., Bussu F., Paludettii G. Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification. Acta Otorhinolaryngol Ital 2006, 26:326-334.
28. Gourin C.G., Conger B.T., Sheils W.C., Bilodeau P.A., Coleman T.A., Porubsky E.S. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009, 119:1312-1317.